Integromics S.L. Integrates GeneBio’s Phenyx within OmicsHub Proteomics
News Sep 23, 2009
OmicsHub Proteomics serve as an end-to-end proteomics data analysis and management system, from protein peak detection to generation of final reports. It has been developed in cooperation with ProteoRed, the Spanish National Proteomics Network, ensuring in this way that the solution is close to the reality of a proteomics laboratory and that it helps to solve the most typical bottlenecks of this field.
Developed in collaboration with the Swiss Institute of Bioinformatics (SIB), Phenyx is GeneBio's renowned software platform for the identification, quantitation and characterization of proteins and peptides from mass spectrometry data. The Phenyx platform is specifically designed to meet the concurrent demands of high-throughput MS data analysis and dynamic results assessment via a customizable architecture and an innovative user-friendly interface. (http://phenyx.vital-it.ch/pwi)
One of the biggest advantages of OmicsHub Proteomics is that we can have integrated in one single platform all the steps of an MS experiment thus reducing time and data management complexity," said Dr. Juan Pablo Albar, General Coordinator of ProteoRed. "As our feedback contributed from the early stages of its creation, OmicsHub Proteomics solves typical problems we find on a daily basis and makes life easier when performing tasks such as multiple search engine support, pathways integration or report generation for external customers. On the other hand, we are glad to see that commercial companies also include in their software functionality which helps laboratories to easily meet proteomics standards such as PRIDE or MIAPE. Since Phenyx is widely used within our network due to its unique capabilities for protein identification, OmicsHub enables our members to take a greater advantage of a central solution like Phenyx.
We are pleased with the integration of Phenyx within OmicsHub Proteomics as this should open up Phenyx to a host of new users,” said Nasri Nahas, CEO of GeneBio. “The OmicsHub Proteomics platform answers proteomics researchers’ needs for proteomics data automation and data management/analysis; combined with the outstanding performance of Phenyx, we envision a winning platform that will immediately bring great value to users and at the same time instantly expand the potential Phenyx user base. We are excited about the future possibilities of this relationship.
Pre-Diabetes Discovery Marks Step Towards Precision MedicineNews
Identification of three molecules that can be used to accurately assess pre-diabetes – a key predictor of conditions such as diabetes and high blood pressure – has brought precision medicine for humans a step closer.READ MORE
High-Resolution Mass Spectrometry Reveals Pathways in Photosystem II Water SystemNews
Researchers have capitalised on the incredible accuracy, speed and sensitivity of new mass spectrometry instruments to provide the first comprehensive study of how an ancient photosynthetic organism uses and regulates water to create energy.READ MORE
SCIEX Announces Joint Venture with Zhenjang Dian Diagnostics in ChinaNews
Leading diagnostics companies combine to address diagnostic and wellness testing in China.READ MORE